FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2157440365> ?p ?o ?g. }

• W2157440365 endingPage "1755" @default.
• W2157440365 startingPage "1746" @default.
• W2157440365 abstract "In mouse models of diabetes, prophylactic administration of insulin reduced incidence of the disease. We investigated whether administration of nasal insulin decreased the incidence of type 1 diabetes, in children with HLA genotypes and autoantibodies increasing the risk of the disease.At three university hospitals in Turku, Oulu, and Tampere (Finland), we analysed cord blood samples of 116 720 consecutively born infants, and 3430 of their siblings, for the HLA-DQB1 susceptibility alleles for type 1 diabetes. 17 397 infants and 1613 siblings had increased genetic risk, of whom 11 225 and 1574, respectively, consented to screening of diabetes-associated autoantibodies at every 3-12 months. In a double-blind trial, we randomly assigned 224 infants and 40 siblings positive for two or more autoantibodies, in consecutive samples, to receive short-acting human insulin (1 unit/kg; n=115 and n=22) or placebo (n=109 and n=18) once a day intranasally. We used a restricted randomisation, stratified by site, with permuted blocks of size two. Primary endpoint was diagnosis of diabetes. Analysis was by intention to treat. The study was terminated early because insulin had no beneficial effect. This study is registered with ClinicalTrials.gov, number NCT00223613.Median duration of the intervention was 1.8 years (range 0-9.7). Diabetes was diagnosed in 49 index children randomised to receive insulin, and in 47 randomised to placebo (hazard ratio [HR] 1.14; 95% CI 0.73-1.77). 42 and 38 of these children, respectively, continued treatment until diagnosis, with yearly rates of diabetes onset of 16.8% (95% CI 11.7-21.9) and 15.3% (10.5-20.2). Seven siblings were diagnosed with diabetes in the insulin group, versus six in the placebo group (HR 1.93; 0.56-6.77). In all randomised children, diabetes was diagnosed in 56 in the insulin group, and 53 in the placebo group (HR 0.98; 0.67-1.43, p=0.91).In children with HLA-conferred susceptibility to diabetes, administration of nasal insulin, started soon after detection of autoantibodies, could not be shown to prevent or delay type 1 diabetes." @default.
• W2157440365 created "2016-06-24" @default.
• W2157440365 creator A5000141478 @default.
• W2157440365 creator A5001640598 @default.
• W2157440365 creator A5011615849 @default.
• W2157440365 creator A5011722240 @default.
• W2157440365 creator A5025203436 @default.
• W2157440365 creator A5029561782 @default.
• W2157440365 creator A5032913883 @default.
• W2157440365 creator A5034345388 @default.
• W2157440365 creator A5059391095 @default.
• W2157440365 creator A5064718624 @default.
• W2157440365 creator A5064931375 @default.
• W2157440365 creator A5066077897 @default.
• W2157440365 creator A5066081714 @default.
• W2157440365 creator A5066618511 @default.
• W2157440365 creator A5075640419 @default.
• W2157440365 creator A5082448955 @default.
• W2157440365 creator A5086871639 @default.
• W2157440365 creator A5089367639 @default.
• W2157440365 creator A5089873556 @default.
• W2157440365 date "2008-11-01" @default.
• W2157440365 modified "2023-10-10" @default.
• W2157440365 title "Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial" @default.
• W2157440365 cites W1554333697 @default.
• W2157440365 cites W1972735675 @default.
• W2157440365 cites W1980780381 @default.
• W2157440365 cites W1984451487 @default.
• W2157440365 cites W2001295992 @default.
• W2157440365 cites W2002434849 @default.
• W2157440365 cites W2006260488 @default.
• W2157440365 cites W2008171808 @default.
• W2157440365 cites W2009721531 @default.
• W2157440365 cites W2014822696 @default.
• W2157440365 cites W2017577067 @default.
• W2157440365 cites W2029196267 @default.
• W2157440365 cites W2040011173 @default.
• W2157440365 cites W2044643317 @default.
• W2157440365 cites W2046806236 @default.
• W2157440365 cites W2057159752 @default.
• W2157440365 cites W2084080341 @default.
• W2157440365 cites W2084732601 @default.
• W2157440365 cites W2087186637 @default.
• W2157440365 cites W2102243639 @default.
• W2157440365 cites W2116137339 @default.
• W2157440365 cites W2116943672 @default.
• W2157440365 cites W2132216352 @default.
• W2157440365 cites W2134293572 @default.
• W2157440365 cites W2136927925 @default.
• W2157440365 cites W2153644370 @default.
• W2157440365 cites W2776280 @default.
• W2157440365 cites W3102907654 @default.
• W2157440365 cites W35963623 @default.
• W2157440365 cites W4233562854 @default.
• W2157440365 cites W614574849 @default.
• W2157440365 doi "https://doi.org/10.1016/s0140-6736(08)61309-4" @default.
• W2157440365 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18814906" @default.
• W2157440365 hasPublicationYear "2008" @default.
• W2157440365 type Work @default.
• W2157440365 sameAs 2157440365 @default.
• W2157440365 citedByCount "335" @default.
• W2157440365 countsByYear W21574403652012 @default.
• W2157440365 countsByYear W21574403652013 @default.
• W2157440365 countsByYear W21574403652014 @default.
• W2157440365 countsByYear W21574403652015 @default.
• W2157440365 countsByYear W21574403652016 @default.
• W2157440365 countsByYear W21574403652017 @default.
• W2157440365 countsByYear W21574403652018 @default.
• W2157440365 countsByYear W21574403652019 @default.
• W2157440365 countsByYear W21574403652020 @default.
• W2157440365 countsByYear W21574403652021 @default.
• W2157440365 countsByYear W21574403652022 @default.
• W2157440365 countsByYear W21574403652023 @default.
• W2157440365 crossrefType "journal-article" @default.
• W2157440365 hasAuthorship W2157440365A5000141478 @default.
• W2157440365 hasAuthorship W2157440365A5001640598 @default.
• W2157440365 hasAuthorship W2157440365A5011615849 @default.
• W2157440365 hasAuthorship W2157440365A5011722240 @default.
• W2157440365 hasAuthorship W2157440365A5025203436 @default.
• W2157440365 hasAuthorship W2157440365A5029561782 @default.
• W2157440365 hasAuthorship W2157440365A5032913883 @default.
• W2157440365 hasAuthorship W2157440365A5034345388 @default.
• W2157440365 hasAuthorship W2157440365A5059391095 @default.
• W2157440365 hasAuthorship W2157440365A5064718624 @default.
• W2157440365 hasAuthorship W2157440365A5064931375 @default.
• W2157440365 hasAuthorship W2157440365A5066077897 @default.
• W2157440365 hasAuthorship W2157440365A5066081714 @default.
• W2157440365 hasAuthorship W2157440365A5066618511 @default.
• W2157440365 hasAuthorship W2157440365A5075640419 @default.
• W2157440365 hasAuthorship W2157440365A5082448955 @default.
• W2157440365 hasAuthorship W2157440365A5086871639 @default.
• W2157440365 hasAuthorship W2157440365A5089367639 @default.
• W2157440365 hasAuthorship W2157440365A5089873556 @default.
• W2157440365 hasConcept C120665830 @default.
• W2157440365 hasConcept C121332964 @default.
• W2157440365 hasConcept C126322002 @default.
• W2157440365 hasConcept C134018914 @default.
• W2157440365 hasConcept C142724271 @default.

• next